Rupatadine effective in the treatment of chronic spontaneous urticaria in children aged 2‐11 years: a randomized, double blind, placebo and desloratadine controlled study
ConclusionThis is the first study to use a modified UAS to assess severity and outcome in CSU in children. Rupatadine is effective in the relief of urticaria symptoms and quality of life over 6 weeks in children with chronic spontaneous urticaria.This article is protected by copyright. All rights reserved.
Source: Pediatric Allergy and Immunology - Category: Allergy & Immunology Authors: Paul Potter, Essack Mitha, Laszlo Barkai, Mezei Gyorgyl, Eva Santamaria, Iñaki Izquierdo, Marcus Maurer Tags: Original Article Source Type: research
More News: Allergy | Allergy & Immunology | Children | Clarinex | Hives | Pediatrics | Statistics | Study